PharmiWeb.com - Global Pharma News & Resources

Articles

Disease modeling involves creating representative systems that mimic the behavior and progression of infectious and noninfectious diseases in a controlled environment. AI’s comprehensive role in this process includes aiding in data processing, simulation and result interpretation. Even if only a handful of teams adopt it, their ability to process and generate results will accelerate progression throughout the field.
Artificial intelligence’s role in disease modeling could be transformative. Its ability to analyze massive datasets rapidly, uncover hidden trends and forecast likely outcomes could accelerate progression in the pharmaceutical industry. How can research teams use this technology to enhance, refine or reimagine their existing processes? How Does AI Fit Into Disease Modeling? Dise…
The global Health Economics and Outcomes Research (HEOR) Services Market size was valued at over $1 billion in 2022 and is estimated to grow at more than 14% CAGR from 2023 to 2032, reaching a value of over $3.5 billion.
The global Health Economics and Outcomes Research (HEOR) Services Market size was valued at over $1 billion in 2022 and is estimated to grow at more than 14% CAGR from 2023 to 2032, reaching a value of over $3.5 billion. The key drivers of this growth are expected to be: A surge in the number of clinical trials globally Focus of pharma & biotech companies on new drug development Increasing R&D expenditure worldwide Growing outsourcing of R&D activities Despite the vast growth expected of the field over the coming years, perhaps the biggest challenge being face…
The pharmaceutical robots market is set for remarkable growth, driven by an increased prevalence of chronic diseases and a heightened demand for automation in healthcare. Valued at $177.9 million in 2022, this market is expected to advance at a compound annual growth rate (CAGR) of 10.3%, reaching an impressive $426.8 million by the end of 2031.
The pharmaceutical robots market is set for remarkable growth, driven by an increased prevalence of chronic diseases and a heightened demand for automation in healthcare. Valued at $177.9 million in 2022, this market is expected to advance at a compound annual growth rate (CAGR) of 10.3%, reaching an impressive $426.8 million by the end of 2031. The Automation Transformation: A New Era in Healthcare Pharmaceutical robots are revolutionizing the heal…
Roots analysis has released the latest market research report on the Pea Protein market, offering a comprehensive analysis of global industry size, and delving deeply into various segments covered in the study report.
Roots analysis has released the latest market research report on the Pea Protein market, offering a comprehensive analysis of global industry size, and delving deeply into various segments covered in the study report. Additionally, the report covers an in-depth study of current industry statistics, market size, regional insight, revenue share, growing segments, product portfolio, and production & distribution costs associated with the global Pea Protein Market. Besides growth insight, the market study report also identifies several factors influencing overall market growth…
This article will explore what a monopoly pharma franchise is, how it works, and why it has become a preferred choice for businesses looking to establish a presence in the pharmaceutical industry.
What Is a Monopoly Pharma Franchise and How Does It Work? The pharmaceutical industry is one of the most rapidly expanding sectors globally, and with it, various business models have emerged, offering opportunities to entrepreneurs and companies alike. One such business model is the monopoly pharma franchise, which has gained significant attention due to its unique structure and profitability. This article will explore what a monopoly pharma franchise is, how it works, and why it has become a preferred choice for businesses looking to establish a presence in the pharmaceutical industry. What Is a…
Some of the major factors driving this growth of respiratory disease vaccines include the rising prevalence of respiratory infections such as influenza, pneumonia, and COVID-19, particularly in vulnerable populations like the elderly and children.
The respiratory disease vaccine market is expected to cross USD 73.34 billion by year 2032, observing around 1.3% CAGR between 2024 and 2032, says a report by Fundamental Business Insights. Some of the major factors driving this growth include the rising prevalence of respiratory infections such as influenza, pneumonia, and COVID-19, particularly in vulnerable populations like the elderly and children. An aging global population also contributes to increased rates of chronic respiratory conditions like COPD and asthma, further boosting vaccine dem…
Healthcare professionals online have backed NICE's decision not to recommend new Alzheimer's treatment Lecanemab for use on the NHS, according to recent research by Creation Healthcare.
Healthcare professionals have taken to social media to praise the National Institute for Health and Care Excellence’s (NICE) decision to reject a new Alzheimer’s treatment for use on the NHS as “rational and sensible”, according to recent research.  An analysis of the social media conversations of healthcare professionals immediately following the health body’s announcement that it would not recommend Lecanemab for use on the NHS found that HCPs were broadly in agreement with the decision.  On the 22nd August, NICE published draft guidance that suggested the amyloid plaque-targeting treatment was “…
Health Economics and Outcomes Research (HEOR) plays a critical role in informing healthcare decisions by assessing the value of medical treatments and interventions. By evaluating costs, clinical outcomes, and patient experiences, HEOR provides evidence to help optimise healthcare spending and improve patient care.
Health Economics and Outcomes Research (HEOR) plays a critical role in informing healthcare decisions by assessing the value of medical treatments and interventions. By evaluating costs, clinical outcomes, and patient experiences, HEOR provides evidence to help optimise healthcare spending and improve patient care. As the demand for more efficient and personalised healthcare systems grows, artificial intelligence (AI) has proven to be a transformative force in HEOR. With the pote…
Mohib Rahmani, Managing Principal at operations transformation consultancy Argon & Co highlights the steps that pharmaceutical firms can take to optimise their inventories, unlock substantial stock savings, and free up capital which would otherwise lie dormant on the warehouse floor.
The pandemic spun the pharmaceutical industry into overdrive, with many firms seeing their sales skyrocket as the demand for vaccines and life-saving medicines accelerated. Some of the largest firms in the pharma industry saw their revenues rise to record heights during the pandemic. Now, the challenge is to sustain this growth and ensure that profits are reinvested in research and development to enhance patient outcomes. However, pharma firms have been far from immune to the cash flow challenges gripping globa…
Biologics CDMO Market, By Type (Mammalian, Non-Mammalian), By Product Type (Biologics (Recombinant Proteins, Vaccines, Monoclonal, Antisense & Molecular Therapy, and Other Biologics) and Biosimilars)
Introduction In recent years, the biologics market has witnessed exponential growth, driven by the increasing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Central to this surge is the pivotal role played by Contract Development and Manufacturing Organizations (CDMOs). These specialized service providers are integral to the biopharmaceutical industry, offering comprehensive support from early-stage development to large-scale commercial production. This article delves into the current trends, challenges, and future prospects of the Biologics CDMO M…
Artificial Intelligence (AI) is transforming industries across the globe, and its impact on the pharmaceutical and biotechnology sectors is particularly profound. By harnessing AI, these industries are not only accelerating drug discovery but also improving the precision and efficiency of therapeutic development.
Artificial Intelligence (AI) is transforming industries across the globe, and its impact on the pharmaceutical and biotechnology sectors is particularly profound. By harnessing AI, these industries are not only accelerating drug discovery but also improving the precision and efficiency of therapeutic development. This article explores the key innovations driven by AI, the technological advancements enhancing gene editing, and the implications for future therapies. Revolutionizing D…
In an industry like the life sciences where specialised knowledge and cross-disciplinary collaboration are key, mentoring can bridge skill gaps, support career advancement, and enhance leadership capabilities. It has also proven to improve employee engagement, retention, and overall performance, with retention rates for employees with mentors 72% higher than those without one.
In an industry like the life sciences where specialised knowledge and cross-disciplinary collaboration are key, mentoring can bridge skill gaps, support career advancement, and enhance leadership capabilities. It has also proven to improve employee engagement, retention, and overall performance, with retention rates for employees with mentors 72% higher than those without one. In this article, we explore 12 different…
The Global Hormone Replacement Therapy Market Size accounted for USD 21.6 Billion in 2022 and is projected to achieve a market size of of USD 39.8 Billion by 2032 growing at a CAGR of 6.4% from 2023 to 2032.
According to Acumen Research and Consulting, The Global Hormone Replacement Therapy Market Size accounted for USD 21.6 Billion in 2022 and is projected to achieve a market size of of USD 39.8 Billion by 2032 growing at a CAGR of 6.4% from 2023 to 2032. Hormone Replacement Therapy (HRT) has emerged as a critical component in the management of hormonal imbalances, particularly for menopause-related symptoms in women. As the global population ages and awareness around hormonal health grows, the HRT market is experiencing significant evolution. This article explores the competitiv…
This article offers an overview of nucleic acid vaccine adjuvant development, exploring its process, technological platforms, applications, and relevance.
Introduction Vaccines are pivotal in the prevention and control of infectious diseases. With advancements in biotechnology, nucleic acid vaccines, such as DNA and RNA vaccines, have emerged as a promising frontier in immunization strategies. Nucleic acid vaccines work by introducing genetic material into the body, instructing cells to produce antigens that trigger immune responses. To enhance the efficacy of these vaccines, adjuvants play an essential role. This article offers an overview of nucleic acid vaccine adjuvant development, exploring its process, technological platforms, applications, and relevance. What are Vaccine Adjuvants? V…
A Pharmaceutical Engineer is a specialised professional who applies chemical engineering, biology, and material science principles to the design, development, and manufacturing of pharmaceutical products. Their role is crucial in ensuring that medications are produced efficiently, safely, and in compliance with strict regulatory standards.
A Pharmaceutical Engineer is a specialised professional who applies chemical engineering, biology, and material science principles to the design, development, and manufacturing of pharmaceutical products. Their role is crucial in ensuring that medications are produced efficiently, safely, and in compliance with strict regulatory standards. They work on the entire lifecycle of a drug, from its initial concept through to its production and quality assurance…
Nanobodies, also known as single-domain antibodies, have gained much attention in recent years due to their potential in various biomedical applications including drug delivery systems.
Nanobodies are small antibody fragments derived from naturally occurring heavy-chain antibodies found in camelids, such as camels and llamas. They are composed of a single monomeric variable domain, making them much smaller than conventional antibodies.   The development of nanobody-based drug delivery systems began with the discovery of camelid antibodies in the early 1990s. These antibodies were found to have several unique properties that made them ideal candidates for drug delivery applications. One of the key advantages of nanobodies is their small size, which allows them to penetrate tissues…
With advancements in extraction techniques and analytical methods, the field of natural product extraction continues to evolve, offering new opportunities for discovering and utilizing the vast potential of nature's bounty.
Natural product extraction is a crucial process in the fields of chemistry, biology, and pharmaceuticals. It involves isolating bioactive compounds from plants, animals, and other natural sources to study their properties and potential applications in various industries.   There are several methods used for natural product extraction, each with its advantages and limitations. One of the most common methods is solvent extraction, where a solvent is used to dissolve the bioactive compounds from the natural source. The solvent is then evaporated, leaving behi…
As technology progresses and new methodologies emerge, the potential applications of stable isotope labeled amino acids will continue to expand, offering new avenues for advancing our understanding of complex biological processes and enhancing human health.
Stable isotope labeled amino acids have emerged as indispensable tools for researchers in the fields of biology and medicine, offering unique opportunities to delve into complex biological processes at the molecular level. These specially labeled amino acids, though chemically identical to their natural counterparts, possess isotopic substitutions that make them easily distinguishable and traceable within biological systems. This article explores the diverse applications of stable isotope labeled amino acids, highlighting how they h…
Veterinary APIs are the chemical substances within medications that produce the intended effects in treating animal diseases.
Introduction In the world of veterinary medicine, maintaining animal health is paramount, not only for the well-being of the animals but also to protect public health and ensure food safety. Integral to achieving this are veterinary active pharmaceutical ingredients (APIs) and their intermediates. These components are the backbone of effective veterinary drugs, providing the essential elements that combat diseases in animals. In this article, we dive deep into the significance of Veterinary APIs, the intricacies of their process development, and the customization of veterinary intermediates.   Importance of Veterinary APIs Veterinary APIs are the chemi…
In the realm of cosmetics, the integration of plant extracts has sparked significant interest due to their diverse benefits and natural origins.
In the realm of cosmetics, the integration of plant extracts has sparked significant interest due to their diverse benefits and natural origins.  Plant Extracts for Moisturizing Moisturizing is a fundamental aspect of skincare, and plant extracts play a pivotal role in this domain. The polysaccharides and glycosides in plant extracts contain hydroxyl groups in their structures, which enable them to retain water through hydrogen bonds. Most plant polysaccharides have hygroscopic properties, such as aloe polysaccharides, which are the main active ingredients of aloe extracts and are widely used moisturizing raw materials in cosmetics. In a…